That meeting, held in Copenhagen the 27-31 May gathered worldwide international experts in adipose tissue plasticity. Albert Mestres, PhD, and Marion Peyrou, recently appointed with the prestigious "Ramon y Cajal" researcher position at the University of Barcelona, presented, together with the PI researcher Dr Marta Giralt, the last results of our team on brown adipose tissue signaling properties.
Francesc Villarroya was invited to present our novel findings on human brown adipose tissue adipokines (batokines) recently identified in our laboratory. ENDO2024 was the annual meeting of the Endocrine Society in USA, held in Boston the 1-4 June, 2024.
The journal Treballs de la Societat Catalana de Biologia (Societat Catalana de Biologia, associated with Institut d'Estudis Catalans) published the issue 73 (2023), open access (Treballs de la Societat Catalana de Biologia), devoted to women in biological sciences, on occasion of the "International Day of Women and Girls in Science". Marta Giralt, full professor at our research team, coordinated this publication together with Gemma Marfany from the Department of Genetics at our University,. Roser Iglesias, also at our research team, contributes with a biographical report on Gabriela Morreale, a pioneer woman in endocrinology research.
Our team contributed with an invited presentation, oral communication and poster presentation by Francesc Villarroya, Albert Blasco-Roset and Albert Mestres-Arenas in relation to the identification of novel batokines involved in the control of adiposity and metabolism. Fruitful interactions with the Spanish community involved in basic and clinical research on obesity has been developed.
Devoted to interdisciplinary research on the role of adipose tissue in health and disease. The ADIPOBROAD network has been awarded by the Ministry of Science to coordinate research on adipobiology and undertake innovative research on emerging issues such as the importance of gender in adipose tissue, climate change and adiposity, or the key role of adipose tissue in cancer and aging. Ten research teams across Spain, placed at Cordoba, Santiago de Compostela, Pamplona, Tarragona, Girona, Madrid, Valencia and Barcelona will act as members of the network.
Increased adiposity is a current concern in people living with HIV treated with the last-generation antiretroviral drugs of the integrase inhibitor family. The platform NAM-AIDSMAP, devoted to provision of independent, accurate & accessible information about HIV, highlights our findings recently published in Life Sciences (doi: 10.1016/j.lfs.2022.120948). We showed that the integrase inhibitor dolutegravir suppresses the production of adiponectin, a chemical secreted by fat tissue that regulates insulin sensitivity, which provides further evidence that dolutegravir can have direct effects on the human cells that store fat (see https://www.aidsmap.com/news/oct-2022/dolutegravir-has-direct-effects-fat-cells).
Francesc Villarroya, as invited speaker, Tania Quesada, through a selected communication, and Moisès Castellà through a poster communication, presented our current research on inter-organ singaling and molecular actors involved in metabolism and adipose tissue thermogenic plasticity at the EMBO meeting held in Málaga last 3 to 6 October.
